Clovis Oncology (CLVS) Misses Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts CLVS Hot Sheet
Join SI Premium – FREE
Clovis Oncology (NASDAQ: CLVS) reported Q2 EPS of ($2.10), $0.01 worse than the analyst estimate of ($2.09).
For earnings history and earnings-related data on Clovis Oncology (CLVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Grandstand Limited (GRSD) Tops Q2 EPS by 5c; Offers Guidance
- StoneCo (STNE) Reports In-Line Q2 EPS
- Veritone (VERI) Misses Q2 EPS by 13c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
